AA Medical
Full Prescribing Info
Each ml contains 5 mg of levofloxacin.
Susceptible strains: Staphylococcus (methicillin-susceptible strains only). Streptococcus, Micrococcus, Enterococcus, Corynebacterium, Pseudomonas, Stenotrophomonas (xanthomonas) maltophilia, Pseudomonas aeruginosa, Haemophilus influenzae, Haemophilus aegyptius (Koch-Weeks Bacillus), Moraxella, Serratia, Klebsiella, Proteus, Morganella morganii, Acinetobacter, Enterobacter.
Uses: Blepharitis, Sty, Dacryocystitis, Conjunctivitis, Aseptic therapy during ophthalmic operation.
Dosage/Direction for Use
Instill one drop into eyes, 3 times daily.
Patients who have a history of hypersensitivity to this preparation or Quinolone antibiotics.
Special Precautions
In use of levofloxacin, susceptibility is identified to prevent resistant strain from multiplying. Levofloxacin is used during the minimum period required for therapeutic benefit.
Prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If superinfection occurs, discontinue use and institute alternative therapy.
Efficacy of levofloxacin for MRSA (Methicillin-resistant Staphylococcus aureus) has not been proven.
Pediatric use: Safety and effectiveness in infants below the age of one year have not been established.
Use In Pregnancy & Lactation
There are, however, no adequate and well-controlled studies in pregnant women. Levofloxacin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
When this preparation is administered to a nursing mother, nursing is discontinued or this therapy is discontinued.
Adverse Reactions
Shock: Rarely symptoms like shock (nausea, cold sense of limb, dyspnea) may occur. In the case that acknowledged as abnormality, therapy is discontinued and appropriate measures are taken.
Hypersensitivity: Rarely cardiovascular collapse, Apsychia, Angioedema (including laryngeal, pharyngeal or facial edema), airway obstruction, dyspnea, rash, urticaria, itching, blepharal flare edema, skin flare and conjunctival injection may occur. In the event of these symptoms, this therapy is discontinued.
Eye: Occasionally irritation such as transient burning sense, dysphoria, occasional stinging pain, flare, itching, chemical conjunctivitis and keratitis, circumbulbar or facial edema, foreign body sensation, dazzling, blurred vision, tears, dryness, eye pain, rarely dizziness, corneal disorder such as lamellar keratitis and Stevens-Johnson syndrome that can become toxic epidermal necrolysis may occur. In the event of these symptoms, therapy is discontinued.
Caution For Usage
Ophthalmic use only.
When using the eye drops care should be taken not to touch the dropper tip to the eyes.
Not for common use to prevent contamination.
Close stopper immediately after using.
Protect from sun light and store in a dry and cool place.
To keep drug quality and to prevent misuse, don't change the original container.
Store below 25°C.
Shelf-Life: 36 months from the manufacturing date.
MIMS Class
Eye Anti-Infectives & Antiseptics
ATC Classification
J01MA12 - levofloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.
Ophth soln 5 mg/mL (light yellow, transparent) x 5 mL x 1's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in